216 related articles for article (PubMed ID: 30614674)
41. Isoprenoid biosynthesis via the MEP pathway. Synthesis of (3,4)-3,4-dihydroxy-5-oxohexylphosphonic acid, an isosteric analogue of 1-deoxy-D-xylulose 5-phosphate, the substrate of the 1-deoxy-D-xylulose 5-phosphate reducto-isomerase.
Meyer O; Grosdemange-Billiard C; Tritsch D; Rohmer M
Org Biomol Chem; 2003 Dec; 1(24):4367-72. PubMed ID: 14685307
[TBL] [Abstract][Full Text] [Related]
42. Rapid and flexible synthesis of 1-deoxy-D-xylulose-5-phosphate, the substrate for 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
Cox RJ; de Andrés-Gómez A; Godfrey CR
Org Biomol Chem; 2003 Sep; 1(18):3173-7. PubMed ID: 14527148
[TBL] [Abstract][Full Text] [Related]
43. A hypoxia-activated antibacterial prodrug.
Yeoh YQ; Horsley JR; Polyak SW; Abell AD
Bioorg Med Chem Lett; 2020 Jun; 30(11):127140. PubMed ID: 32247730
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and Evaluation of Fluoroalkyl Phosphonyl Analogues of 2- C-Methylerythritol Phosphate as Substrates and Inhibitors of IspD from Human Pathogens.
Bartee D; Wheadon MJ; Freel Meyers CL
J Org Chem; 2018 Sep; 83(17):9580-9591. PubMed ID: 29870251
[TBL] [Abstract][Full Text] [Related]
45. Phage Display on the Anti-infective Target 1-Deoxy-d-xylulose-5-phosphate Synthase Leads to an Acceptor-Substrate Competitive Peptidic Inhibitor.
Marcozzi A; Masini T; Zhu D; Pesce D; Illarionov B; Fischer M; Herrmann A; Hirsch AKH
Chembiochem; 2018 Jan; 19(1):58-65. PubMed ID: 29119720
[TBL] [Abstract][Full Text] [Related]
46. Functional and evolutionary analysis of DXL1, a non-essential gene encoding a 1-deoxy-D-xylulose 5-phosphate synthase like protein in Arabidopsis thaliana.
Carretero-Paulet L; Cairó A; Talavera D; Saura A; Imperial S; Rodríguez-Concepción M; Campos N; Boronat A
Gene; 2013 Jul; 524(1):40-53. PubMed ID: 23154062
[TBL] [Abstract][Full Text] [Related]
47. A high-throughput screening assay for simultaneous selection of inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate synthase (Dxs) or 1-deoxy-D-xylulose 5-phosphate reductoisomerase (Dxr).
Humnabadkar V; Jha RK; Ghatnekar N; De Sousa SM
J Biomol Screen; 2011 Mar; 16(3):303-12. PubMed ID: 21335601
[TBL] [Abstract][Full Text] [Related]
48. MCR-1 Inhibition with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Sensitivity to Polymyxin in
Daly SM; Sturge CR; Felder-Scott CF; Geller BL; Greenberg DE
mBio; 2017 Nov; 8(6):. PubMed ID: 29114023
[TBL] [Abstract][Full Text] [Related]
49. Targeting the MraY and MurG bacterial enzymes for antimicrobial therapeutic intervention.
Zawadzke LE; Wu P; Cook L; Fan L; Casperson M; Kishnani M; Calambur D; Hofstead SJ; Padmanabha R
Anal Biochem; 2003 Mar; 314(2):243-52. PubMed ID: 12654311
[TBL] [Abstract][Full Text] [Related]
50. Isoprenoid biosynthesis via the methylerythritol phosphate pathway. Mechanistic investigations of the 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
Hoeffler JF; Tritsch D; Grosdemange-Billiard C; Rohmer M
Eur J Biochem; 2002 Sep; 269(18):4446-57. PubMed ID: 12230556
[TBL] [Abstract][Full Text] [Related]
51. Mutations in Escherichia coli aceE and ribB genes allow survival of strains defective in the first step of the isoprenoid biosynthesis pathway.
Perez-Gil J; Uros EM; Sauret-Güeto S; Lois LM; Kirby J; Nishimoto M; Baidoo EE; Keasling JD; Boronat A; Rodriguez-Concepcion M
PLoS One; 2012; 7(8):e43775. PubMed ID: 22928031
[TBL] [Abstract][Full Text] [Related]
52. Site-Specific Antimicrobial Activity of a Dual-Responsive Ciprofloxacin Prodrug.
Ross CL; Lawer A; Sircombe KJ; Pletzer D; Gamble AB; Hook S
J Med Chem; 2024 Jun; 67(11):9599-9612. PubMed ID: 38780408
[TBL] [Abstract][Full Text] [Related]
53. Antimicrobial mechanism of epigallocatechin gallate and gallocatechin gallate: They target 1-deoxy-d-xylulose 5-phosphate reductoisomerase, the key enzyme of the MEP terpenoid biosynthetic pathway.
Hui X; Hua SH; Wu QQ; Li H; Gao WY
Arch Biochem Biophys; 2017 May; 622():1-8. PubMed ID: 28428039
[TBL] [Abstract][Full Text] [Related]
54. Structural insights into inhibition of lipid I production in bacterial cell wall synthesis.
Chung BC; Mashalidis EH; Tanino T; Kim M; Matsuda A; Hong J; Ichikawa S; Lee SY
Nature; 2016 May; 533(7604):557-560. PubMed ID: 27088606
[TBL] [Abstract][Full Text] [Related]
55. Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
Wang XL; Zhang YB; Tang JF; Yang YS; Chen RQ; Zhang F; Zhu HL
Eur J Med Chem; 2012 Nov; 57():373-82. PubMed ID: 23124163
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and evaluation of a mechanism-based inhibitor of KDO8P synthase.
Belakhov V; Dovgolevsky E; Rabkin E; Shulami S; Shoham Y; Baasov T
Carbohydr Res; 2004 Jan; 339(2):385-92. PubMed ID: 14698897
[TBL] [Abstract][Full Text] [Related]
57. E. coli MEP synthase: steady-state kinetic analysis and substrate binding.
Koppisch AT; Fox DT; Blagg BS; Poulter CD
Biochemistry; 2002 Jan; 41(1):236-43. PubMed ID: 11772021
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and structure-activity relationship study of novel quinazolinone-based inhibitors of MurA.
Hrast M; Rožman K; Jukič M; Patin D; Gobec S; Sova M
Bioorg Med Chem Lett; 2017 Aug; 27(15):3529-3533. PubMed ID: 28579123
[TBL] [Abstract][Full Text] [Related]
59. Design, synthesis, and application of novel triclosan prodrugs as potential antimalarial and antibacterial agents.
Mishra S; Karmodiya K; Parasuraman P; Surolia A; Surolia N
Bioorg Med Chem; 2008 May; 16(10):5536-46. PubMed ID: 18434169
[TBL] [Abstract][Full Text] [Related]
60. Antimicrobial mechanism of theaflavins: They target 1-deoxy-D-xylulose 5-phosphate reductoisomerase, the key enzyme of the MEP terpenoid biosynthetic pathway.
Hui X; Yue Q; Zhang DD; Li H; Yang SQ; Gao WY
Sci Rep; 2016 Dec; 6():38945. PubMed ID: 27941853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
